IGC · ISSUER CIK 1326205
IGC Pharma, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 IGC Pharma, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 29, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 202616:01 | Sep 25, 2026 | IGC | CEO, Director | G · Gift | — | −200,000 | 6,675,563 | -3% | — | ||
| Sep 29, 202616:00 | Sep 25, 2026 | IGC | PFO, Director | G · Gift | — | −150,000 | 3,271,092 | -4% | — |